ORBIMED ADVISORS LLC - Insider Non-Derivative Transactions at ARS Pharmaceuticals, Inc. (SPRY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 29, 2023, ORBIMED ADVISORS LLC's relationship to ARS Pharmaceuticals, Inc. (SPRY) is Director, and currently has 8,019,187 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SPRY insiders.
Data Source: SEC.
ORBIMED ADVISORS LLC - Insider Non-Derivative Transactions at SPRY
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 30, 2023 | P -- (Common Stock) | 500000 | 6.2 | 8019187 |